Literature DB >> 3230200

The influence of labetalol on arterial blood gas data, pulmonary haemodynamics and pulmonary shunting.

S G De Hert1, L G Heytens, R G De Jongh, M P Vercauteren, E A Boeckx, H F Adriaensen.   

Abstract

The arterial oxygen and carbon dioxide tensions, pulmonary and systemic haemodynamics and pulmonary shunting and mechanics were measured during the first 30 min after intravenous labetalol administration. Thirty patients, recovering in the intensive care unit after neurosurgical interventions were randomly divided in 2 groups of 15 patients, receiving either labetalol or placebo. In the labetalol treated group the arterial oxygen tension decreased from 553.6 +/- 16.8 to 529.3 +/- 19.8 mmHg 5 min after the injection of labetalol. A concomitant increase in arterial carbon dioxide tension from 40.1 +/- 1.1 to 45.5 +/- 1.3 mmHg was noticed. Pulmonary vascular resistance decreased from 159.6 +/- 14.7 to 116.7 +/- 11.7 dynes.sec.cm-5 and pulmonary shunting increased from 4.8% +/- 1.4% to 8.1% +/- 2.4% 5 min following injection. All these changes were statistically significant for p less than 0.01. After 30 min all values had returned to their initial level. No changes were registered in the control group. As airway resistance appeared not to be affected by the labetalol administration it may be concluded that the observed changes in blood gas data are most likely due to a transient decrease of the pulmonary vascular resistance with a concomitant increase in pulmonary shunting.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3230200     DOI: 10.1007/bf00255635

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

1.  Clinical use of a nomogram to estimate proper ventilation during artificial respiration.

Authors:  E P RADFORD; B G FERRIS; B C KRIETE
Journal:  N Engl J Med       Date:  1954-11-25       Impact factor: 91.245

2.  An improved program to calculate intrapulmonary shunting.

Authors:  D Siegel; S Ramanathan; J Chalon; H Turndorf
Journal:  Crit Care Med       Date:  1979-06       Impact factor: 7.598

3.  Intrapulmonary shunting during deliberate hypotension with nifedipine, diltiazem and labetalol in dogs.

Authors:  P A Casthely; R Villanueva; L Rabinowitz; P Gandhi; B Litwak; P N Fyman
Journal:  Can Anaesth Soc J       Date:  1985-03

4.  Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients.

Authors:  R Fagard; A Amery; T Reybrouck; P Lijnen; L Billiet
Journal:  Circulation       Date:  1979-12       Impact factor: 29.690

5.  [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].

Authors:  V Lüben; W Rieder; J Zierski; G Hempelmann
Journal:  Anasth Intensivther Notfallmed       Date:  1981-08

6.  Haemodynamic effects of labetalol-induced hypotension in the anaesthetized dog.

Authors:  C Gustafson; I Ahlgren; K F Aronsen; B Rosberg
Journal:  Br J Anaesth       Date:  1981-06       Impact factor: 9.166

7.  Effect of labetalol on intracranial pressure in dogs with and without intracranial hypertension.

Authors:  H Van Aken; C Puchstein; M L Schweppe; A Heinecke
Journal:  Acta Anaesthesiol Scand       Date:  1982-12       Impact factor: 2.105

Review 8.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.

Authors:  P Lund-Johansen
Journal:  Drugs       Date:  1984       Impact factor: 9.546

Review 9.  Labetalol. Current research and therapeutic status.

Authors:  J D Wallin; W M O'Neill
Journal:  Arch Intern Med       Date:  1983-03

10.  Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.

Authors:  G Koch
Journal:  Am Heart J       Date:  1977-05       Impact factor: 4.749

View more
  1 in total

1.  Beta-blocker treatment in the critically ill: a systematic review and meta-analysis.

Authors:  Maria Heliste; Ville Pettilä; David Berger; Stephan M Jakob; Erika Wilkman
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.